Oldest pages

Jump to navigation Jump to search

Showing below up to 226 results in range #601 to #826.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Waste management‏‎ (15:05, 12 August 2021)
  2. Worker‏‎ (15:08, 12 August 2021)
  3. Working level‏‎ (15:14, 12 August 2021)
  4. Working level month‏‎ (15:17, 12 August 2021)
  5. Adenoma‏‎ (15:24, 12 August 2021)
  6. Air kerma at the patient entrance reference point‏‎ (15:27, 12 August 2021)
  7. Apoptosis‏‎ (15:29, 12 August 2021)
  8. AML/eto‏‎ (15:30, 12 August 2021)
  9. Automatic exposure control‏‎ (15:33, 12 August 2021)
  10. Brachytherapy‏‎ (15:34, 12 August 2021)
  11. Bragg peak‏‎ (15:37, 12 August 2021)
  12. Spread-out Bragg peak‏‎ (15:39, 12 August 2021)
  13. Breakpoint cluster region/abelson‏‎ (15:41, 12 August 2021)
  14. Broad beam therapy irradiation technique‏‎ (15:44, 12 August 2021)
  15. Carers and comforters‏‎ (15:48, 12 August 2021)
  16. Clinical audit‏‎ (15:50, 12 August 2021)
  17. Clonogenic surviving fraction‏‎ (15:52, 12 August 2021)
  18. Cobblestone area forming cell assay‏‎ (15:53, 12 August 2021)
  19. Collimation‏‎ (15:54, 12 August 2021)
  20. Cone beam computed tomography‏‎ (15:56, 12 August 2021)
  21. Dental and maxillofacial imaging‏‎ (16:01, 12 August 2021)
  22. Exposure index‏‎ (16:03, 12 August 2021)
  23. Detector quantum efficiency‏‎ (16:04, 12 August 2021)
  24. Diagnostic reference level‏‎ (16:09, 12 August 2021)
  25. Dose-length product‏‎ (16:11, 12 August 2021)
  26. DRL process‏‎ (16:14, 12 August 2021)
  27. DRL quantity‏‎ (16:18, 12 August 2021)
  28. Exogenous excretion‏‎ (16:19, 12 August 2021)
  29. Functional subunits‏‎ (16:24, 12 August 2021)
  30. Hounsfield unit‏‎ (16:43, 12 August 2021)
  31. Accelerated fractionation‏‎ (16:45, 12 August 2021)
  32. Hyperfractionation‏‎ (16:45, 12 August 2021)
  33. Intensity-modulated radiotherapy‏‎ (16:46, 12 August 2021)
  34. Local DRL‏‎ (16:49, 12 August 2021)
  35. National DRL‏‎ (16:50, 12 August 2021)
  36. DRL value‏‎ (16:51, 12 August 2021)
  37. Mean glandular dose‏‎ (17:28, 12 August 2021)
  38. Multi-detector computed tomography‏‎ (17:31, 12 August 2021)
  39. Multifactorial diseases‏‎ (17:31, 12 August 2021)
  40. Multitarget equation‏‎ (17:37, 12 August 2021)
  41. Noise‏‎ (17:38, 12 August 2021)
  42. Notification value‏‎ (17:41, 12 August 2021)
  43. Nuclear medicine‏‎ (17:42, 12 August 2021)
  44. Molecular imaging‏‎ (17:43, 12 August 2021)
  45. Organ at risk‏‎ (17:44, 12 August 2021)
  46. Oxygen enhancement ratio‏‎ (17:45, 12 August 2021)
  47. Pencil beam‏‎ (17:46, 12 August 2021)
  48. Pilomatricoma‏‎ (17:47, 12 August 2021)
  49. Potential recoverability correction factor‏‎ (17:49, 12 August 2021)
  50. Quality control testing‏‎ (17:51, 12 August 2021)
  51. Radiation-induced second cancer‏‎ (17:52, 12 August 2021)
  52. Radiation-induced secondary malignancy‏‎ (17:53, 12 August 2021)
  53. Ras‏‎ (17:55, 12 August 2021)
  54. Rb‏‎ (17:56, 12 August 2021)
  55. Referrer‏‎ (17:57, 12 August 2021)
  56. Reference air kerma‏‎ (17:59, 12 August 2021)
  57. Regional diagnostic reference levels‏‎ (18:01, 12 August 2021)
  58. Registry‏‎ (18:02, 12 August 2021)
  59. Relative survival‏‎ (18:03, 12 August 2021)
  60. Secondary radiation‏‎ (18:04, 12 August 2021)
  61. Shielding‏‎ (18:05, 12 August 2021)
  62. Size-specific dose estimate‏‎ (18:06, 12 August 2021)
  63. Slice‏‎ (18:07, 12 August 2021)
  64. Standard-size adult‏‎ (18:09, 12 August 2021)
  65. Stem cell‏‎ (18:10, 12 August 2021)
  66. Teratocarcinoma‏‎ (18:11, 12 August 2021)
  67. Time-resolved computed tomography‏‎ (18:13, 12 August 2021)
  68. Tolerance dose‏‎ (18:14, 12 August 2021)
  69. Digital breast tomosynthesis‏‎ (18:15, 12 August 2021)
  70. Treatment preparation in radiotherapy‏‎ (18:16, 12 August 2021)
  71. Typical value‏‎ (18:18, 12 August 2021)
  72. Absorbed fraction‏‎ (18:24, 12 August 2021)
  73. Source region‏‎ (18:27, 12 August 2021)
  74. Activity median aerodynamic diameter‏‎ (18:29, 12 August 2021)
  75. Ambient dose equivalent‏‎ (18:30, 12 August 2021)
  76. Annual intake‏‎ (18:31, 12 August 2021)
  77. Annual limit on intake‏‎ (18:37, 12 August 2021)
  78. Derived air concentration‏‎ (18:41, 12 August 2021)
  79. Biological half-life‏‎ (18:43, 12 August 2021)
  80. Bronchiolar region‏‎ (18:44, 12 August 2021)
  81. Charged-particle equilibrium‏‎ (18:45, 12 August 2021)
  82. Collective effective dose‏‎ (19:04, 12 August 2021)
  83. Compartment‏‎ (19:06, 12 August 2021)
  84. Cross section‏‎ (19:10, 12 August 2021)
  85. Cumulative dose‏‎ (19:11, 12 August 2021)
  86. Deposition‏‎ (19:13, 12 August 2021)
  87. Derived investigation level‏‎ (19:14, 12 August 2021)
  88. Directional dose equivalent‏‎ (19:16, 12 August 2021)
  89. Distribution coefficient‏‎ (19:18, 12 August 2021)
  90. Dose‏‎ (19:22, 12 August 2021)
  91. Absorbed dose‏‎ (19:22, 12 August 2021)
  92. Equivalent dose‏‎ (19:32, 12 August 2021)
  93. Dose commitment‏‎ (19:40, 12 August 2021)
  94. Dose conversion convention‏‎ (19:46, 12 August 2021)
  95. Dose conversion factor‏‎ (19:47, 12 August 2021)
  96. Dose of record (E)‏‎ (19:50, 12 August 2021)
  97. Dose of record Hp (10)‏‎ (19:52, 12 August 2021)
  98. Dose per content function‏‎ (18:26, 17 August 2021)
  99. DS86‏‎ (18:29, 17 August 2021)
  100. DS02‏‎ (18:29, 17 August 2021)
  101. Endosteum‏‎ (18:34, 17 August 2021)
  102. Equieffective dose‏‎ (18:41, 17 August 2021)
  103. Equilibrium equivalent concentration‏‎ (18:43, 17 August 2021)
  104. Equilibrium factor‏‎ (02:06, 18 August 2021)
  105. Excretion rate (instantaneous)‏‎ (02:08, 18 August 2021)
  106. Expanded and aligned radiation field‏‎ (02:11, 18 August 2021)
  107. Expanded radiation field‏‎ (02:12, 18 August 2021)
  108. Exposure (in the context of inhalation)‏‎ (02:14, 18 August 2021)
  109. Extrathoracic airways‏‎ (02:18, 18 August 2021)
  110. Human Respiratory Tract Model‏‎ (02:31, 18 August 2021)
  111. Human Alimentary Tract Model‏‎ (02:33, 18 August 2021)
  112. Gray‏‎ (02:34, 18 August 2021)
  113. Intake‏‎ (02:39, 18 August 2021)
  114. Kerma approximation‏‎ (16:58, 18 August 2021)
  115. Low linear energy transfer radiation‏‎ (17:19, 18 August 2021)
  116. High linear energy transfer radiation‏‎ (17:21, 18 August 2021)
  117. Linear energy transfer‏‎ (17:23, 18 August 2021)
  118. Marrow cellularity‏‎ (17:25, 18 August 2021)
  119. Count median diameter‏‎ (17:38, 18 August 2021)
  120. Mass median diameter‏‎ (17:39, 18 August 2021)
  121. Activity median thermodynamic diameter‏‎ (17:41, 18 August 2021)
  122. Thermodynamic diameter‏‎ (17:42, 18 August 2021)
  123. Measured quantity‏‎ (17:45, 18 August 2021)
  124. Organ/tissue absorbed dose‏‎ (18:14, 18 August 2021)
  125. OLINDA/EXM‏‎ (18:17, 18 August 2021)
  126. Other (systemic) tissues‏‎ (18:23, 18 August 2021)
  127. Particle transport‏‎ (18:24, 18 August 2021)
  128. Dose equivalent‏‎ (18:34, 18 August 2021)
  129. Organ dose equivalent‏‎ (18:36, 18 August 2021)
  130. Personal dose equivalent‏‎ (18:42, 18 August 2021)
  131. Operational quantity‏‎ (18:45, 18 August 2021)
  132. Phantom‏‎ (18:46, 18 August 2021)
  133. Potential alpha energy concentration‏‎ (18:48, 18 August 2021)
  134. Quality factor‏‎ (19:14, 18 August 2021)
  135. Radiation weighting factor‏‎ (19:25, 18 August 2021)
  136. Sievert‏‎ (19:36, 18 August 2021)
  137. Specific effective energy‏‎ (19:40, 18 August 2021)
  138. Dose coefficient‏‎ (18:10, 19 August 2021)
  139. Dose conversion coefficient‏‎ (18:10, 19 August 2021)
  140. Effective dose‏‎ (18:28, 19 August 2021)
  141. Reference individual‏‎ (18:34, 19 August 2021)
  142. Reference parameter value‏‎ (18:35, 19 August 2021)
  143. Reference Person‏‎ (18:39, 19 August 2021)
  144. Reference phantom‏‎ (18:45, 19 August 2021)
  145. Reference worker‏‎ (18:46, 19 August 2021)
  146. S coefficient (radiation weighted)‏‎ (18:57, 19 August 2021)
  147. Specific absorbed fraction‏‎ (19:01, 19 August 2021)
  148. Spongiosa‏‎ (19:04, 19 August 2021)
  149. Thoracic airways‏‎ (19:10, 19 August 2021)
  150. Investigation level‏‎ (19:11, 19 August 2021)
  151. Threshold level‏‎ (19:12, 19 August 2021)
  152. Non-maleficence‏‎ (19:38, 19 August 2021)
  153. Dignity‏‎ (19:51, 19 August 2021)
  154. Beneficence‏‎ (19:51, 19 August 2021)
  155. Prudence‏‎ (19:53, 19 August 2021)
  156. Equity‏‎ (19:55, 19 August 2021)
  157. ALARA‏‎ (20:02, 19 August 2021)
  158. Optimisation‏‎ (20:03, 19 August 2021)
  159. Alimentary tract‏‎ (20:14, 19 August 2021)
  160. Low Earth orbit‏‎ (01:58, 20 August 2021)
  161. Kerma‏‎ (14:12, 7 September 2021)
  162. Employer‏‎ (14:15, 7 September 2021)
  163. Justice‏‎ (14:18, 7 September 2021)
  164. Justification‏‎ (14:18, 7 September 2021)
  165. Kp index‏‎ (14:22, 7 September 2021)
  166. Fairness‏‎ (14:23, 7 September 2021)
  167. Field-size effect (Volume effect)‏‎ (14:23, 7 September 2021)
  168. Flexible tissues‏‎ (14:24, 7 September 2021)
  169. Fluoroscopically guided interventions‏‎ (14:24, 7 September 2021)
  170. Fluence‏‎ (14:24, 7 September 2021)
  171. Fluoroscopically or computed tomography guided interventions‏‎ (14:24, 7 September 2021)
  172. Forbiddenness‏‎ (14:25, 7 September 2021)
  173. Fractional absorption in the gastrointestinal tract‏‎ (14:25, 7 September 2021)
  174. Fractionation‏‎ (14:25, 7 September 2021)
  175. Fractionation and dose delivery patterns‏‎ (14:26, 7 September 2021)
  176. Fractionation sensitivity‏‎ (14:26, 7 September 2021)
  177. Galactic cosmic radiation‏‎ (14:27, 7 September 2021)
  178. Gamma ray‏‎ (14:27, 7 September 2021)
  179. Gastrointestinal syndrome‏‎ (14:27, 7 September 2021)
  180. Gastrulation‏‎ (14:27, 7 September 2021)
  181. Gastroschisis‏‎ (14:28, 7 September 2021)
  182. GATA binding protein 2‏‎ (14:28, 7 September 2021)
  183. Genomic integrity‏‎ (14:28, 7 September 2021)
  184. Rigidity threshold‏‎ (14:29, 7 September 2021)
  185. Graded approach‏‎ (14:29, 7 September 2021)
  186. Graft vs host disease‏‎ (14:29, 7 September 2021)
  187. Granulocyte colony-stimulating factor‏‎ (14:30, 7 September 2021)
  188. Granulocyte-macrophage colony-stimulating factor‏‎ (14:30, 7 September 2021)
  189. Growth factor‏‎ (14:31, 7 September 2021)
  190. Growth fraction‏‎ (14:31, 7 September 2021)
  191. Growth hormone (somatotropin)‏‎ (14:32, 7 September 2021)
  192. X ray‏‎ (14:33, 7 September 2021)
  193. Xerostomia‏‎ (14:33, 7 September 2021)
  194. Value judgement‏‎ (14:33, 7 September 2021)
  195. Valvular heart disease‏‎ (14:34, 7 September 2021)
  196. Virtue ethics‏‎ (14:34, 7 September 2021)
  197. Voxel phantom‏‎ (14:34, 7 September 2021)
  198. Unattached fraction‏‎ (14:55, 7 September 2021)
  199. Unsealed source‏‎ (14:56, 7 September 2021)
  200. Upper reference levels‏‎ (14:56, 7 September 2021)
  201. Uptake‏‎ (14:56, 7 September 2021)
  202. Utilitarian ethics‏‎ (14:57, 7 September 2021)
  203. Cohort study‏‎ (14:21, 3 October 2021)
  204. Lag‏‎ (14:24, 3 October 2021)
  205. Lifetime risk‏‎ (14:28, 3 October 2021)
  206. Absolute risk‏‎ (14:29, 3 October 2021)
  207. Risk‏‎ (14:29, 3 October 2021)
  208. Secretory cells‏‎ (14:31, 3 October 2021)
  209. ICRP Glossary‏‎ (14:37, 3 October 2021)
  210. ICRP Publication 140‏‎ (17:08, 3 October 2021)
  211. ICRP Publication 141‏‎ (17:10, 3 October 2021)
  212. ICRP Publication 142‏‎ (17:10, 3 October 2021)
  213. ICRP Publication 143‏‎ (17:11, 3 October 2021)
  214. ICRP Publication 144‏‎ (17:11, 3 October 2021)
  215. ICRP Publication 145‏‎ (17:12, 3 October 2021)
  216. ICRP Publication 146‏‎ (17:12, 3 October 2021)
  217. ICRP Publication 147‏‎ (17:13, 3 October 2021)
  218. ICRP Publication 148‏‎ (17:13, 3 October 2021)
  219. ICRP Publication 149‏‎ (17:13, 3 October 2021)
  220. ICRP Publication 150‏‎ (17:14, 3 October 2021)
  221. ICRP Publication 151‏‎ (17:14, 3 October 2021)
  222. ICRP Publication 152‏‎ (17:14, 3 October 2021)
  223. ICRP Publication 153‏‎ (17:15, 3 October 2021)
  224. ICRP Publication 154‏‎ (17:15, 3 October 2021)
  225. ICRP Publication 155‏‎ (17:15, 3 October 2021)
  226. ICRP publications‏‎ (17:57, 3 October 2021)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:AncientPages"